RMMS Defeats TRO/PI Motion on ORACEA® (doxycycline) Capsules Small Molecules April 11, 2024 Read More
RMMS Secures Non-Infringement Win on ORACEA® (doxycycline) Capsules Small Molecules April 1, 2024 Read More
Federal Circuit Affirms Judgment Involving DUEXIS® Tablets (800 mg ibuprofen and 26.6 mg famotidine Small Molecules November 16, 2021 Read More
RMMS Secures Non-Infringement and Invalidity Win on BROMSITE® (bromfenac ophthalmic solution) 0.075% Small Molecules October 1, 2021 Read More
RMMS Scores Win in Case Involving DUEXIS® tablets (800 mg ibuprofen and 26.6 mg famotidine) Small Molecules November 30, 2020 Read More
Federal Circuit Affirms Invalidity Judgment Concerning COPAXONE® (Glatiramer Acetate) Small Molecules October 12, 2018 Read More
Federal Circuit Affirms Invalidity Judgment Concerning AXIRON® (Testosterone) Transdermal Solution Medical DevicesSmall Molecules November 22, 2017 Read More
Federal Circuit Affirms Collateral Estoppel Decision Concerning Latisse® (bimatoprost topical solution) Small Molecules March 17, 2017 Read More
RMMS Secures Invalidity Win on Copaxone® 40 (glatiramer acetate 40 mg/mL) Small Molecules January 30, 2017 Read More
RMMS Secures Invalidity And Non-Infringement Victories on Patents Related To Axiron® (Testosterone) Transdermal Solution Medical DevicesSmall Molecules August 22, 2016 Read More
RMMS Recognized As Second Most Active Firm Representing Defendants in Hatch-Waxman Cases Small Molecules April 27, 2016 Read More
Federal Circuit Affirms Judgment of Invalidity Concerning OxyContin® (oxycodone extended-release tablets) Small Molecules February 1, 2016 Read More
RMMS Secures Favorable Claim Construction Ruling In Suit Involving Generic Aripiprazole (Abilify®) Small Molecules November 16, 2015 Read More
RMMS Secures Summary Judgment Against Otsuka Related To Generic Aripiprazole (Abilify®) Small Molecules May 27, 2015 Read More
Federal Circuit Affirms Judgment of Invalidity Concerning Pulmicort Respules® (budesonide inhalation suspension) Small Molecules May 7, 2015 Read More
RMMS Secures Second Victory Against Otsuka Related To Generic Aripiprazole (Abilify®) Small Molecules April 30, 2015 Read More
Chief Judge Simandle Allows Launch of Generic Aripiprazole (Abilify®) Small Molecules April 16, 2015 Read More
Federal Circuit Affirms Invalidity Judgment Concerning Zymaxid®/Zymar® (Gatifloxacin) Ophthalmic Solutions Small Molecules March 20, 2015 Read More
RMMS Secures Judgment of Patent Invalidity Following Remand Trial Involving Generic Pulmicort Respules® (Budesonide Inhalation Suspension) Small Molecules February 13, 2015 Read More
Federal Circuit Affirms Judgment Of Non-Infringement Involving Generic Trizivir® (Abacavir Sulfate, Lamivudine, and Zidovudine) Tablets Small Molecules February 12, 2015 Read More